Sort
21,453 grants matching “tuberculosis”
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.
$147,383Kyle H Rohde · University Of Central Florida · R01 · FY2022 · AI
Sepsis Characterization in Kilimanjaro
$147,318Matthew P Rubach · Duke University · R01 · FY2022 · AI
Inflammatory determinants of disease severity and treatment outcome in TB patients
$147,254Robert John Wilkinson · University Of Cape Town · U01 · FY2017 · AI
HOST RESPONSE EFFECT ON MYCOBACTERIAL GENE EXPRESSION
$147,251University Of Pittsburgh At Pittsburgh · R01 · FY2000 · AI
Cellular and molecular architecture of granulomas in human tuberculous lymphadenitis
$147,240Chaouki Benabdessalem · Institut Pasteur De Tunis · R01 · FY2023 · AI
Administrative Core
$147,166David Branch Moody · Brigham And Women'S Hospital · U19 · FY2021 · AI
Biomarkers of Hepatotoxicity in Women Living with HIV and Latent TB
$147,165Kristina Marie Brooks · University Of Colorado Denver · K08 · FY2020 · AI
Targetting the Niemann-Pick disease type C cellular pathway as a novel approach t
$147,023Frances Mary Platt · University Of Oxford · R21 · FY2013 · AI
Biodiversity of Vietnam and Laos
$147,000Djaja D Soejarto · University Of Illinois At Chicago · U01 · FY2008 · TW
HTS assay and configuration for inhibitors of the UDP-Mur formation pathway
$147,000Michael R McNeil · Colorado State University · R21 · FY2009 · NS
Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South Africa
$147,000Alana Teresa Brennan · Boston University Medical Campus · K01 · FY2020 · DK
Assay Development of M. tuberculosis class II aldolase
$147,000Mary Jackson · Colorado State University · R21 · FY2009 · NS
Kentucky Tuberculosis Elimination and Laboratory Program Cooperative Agreement 2015 to 2019
$146,957Robert L. Brawley · Ky St Cabinet/Health/Family Services · U52 · FY2016 · PS
Mali International Center for Excellence in Research: Filariasis
$146,894Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Defining drivers of TB transmission in the era of universal ART, and implications for finding the walking well
$146,781Alison Grant · London Sch/Hygiene & Tropical Medicine · R01 · FY2023 · AI
Intercellular trafficking of labeled aminoglycosides in living hair cells
$146,775Dale Warren Hailey · University Of Washington · R03 · FY2013 · DC
Measuring spillover effects of reactive, focal malaria elimination interventions
$146,767Jade Benjamin-Chung · Stanford University · K01 · FY2021 · AI
Mechanisms of adverse effects of anti-tuberculosis drugs
$146,759Xiaochao Ma · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · DK
Adaptation, fitness and resistance in rifampicin-resistant M. tuberculosis
$146,753Elizabeth Maria Streicher · Stellenbosch University · R01 · FY2020 · AI
Household contact tuberculosis preventive therapy program in rural Eastern Cape, South Africa
$146,750Brittney Jayne Van De Water · Harvard Medical School · K23 · FY2020 · NR
Household contact tuberculosis preventive therapy program in rural Eastern Cape, South Africa
$146,750Brittney Jayne Van De Water · Boston College · K23 · FY2022 · NR
PATHOGENESIS OF INFECTIOUS DISEASES TRAINING PROGRAM
$146,745Weill Medical College Of Cornell Univ · T32 · FY2001 · AI
Point-of-care detection of TB and NTM pathogens with Fluorescent Deoxyribozyme Sensors and 3D-printed, battery powered device.
$146,590Kyle H Rohde · University Of Central Florida · R01 · FY2021 · AI
DEVELOPMENT OF A NOVEL PEDIATRIC COMBINATION VACCINE AGAINST HIV & TB INFECTION
$146,581Kristina Abel · University Of California At Davis · P51 · FY2009 · RR
Measuring spillover effects of reactive, focal malaria elimination interventions
$146,578Jade Benjamin-Chung · University Of California Berkeley · K01 · FY2020 · AI